Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

BioLife Solutions, Inc. (BLFS) had Revenue of $25.42M for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$25.42M
Net Income	$-15.84M
Cost of Goods Sold	$8.99M
Gross Profit	$16.43M
Operating Expenses	$42.06M
Operating Income	$-16.64M
Non-Operating Income/Expense	$0.93M
Pre-Tax Income	$-15.71M
Normalized Pre-Tax Income	$-15.71M
Income after Taxes	$-15.84M
Income from Continuous Operations	$-15.84M
Consolidated Net Income/Loss	$-15.84M
Normalized Income after Taxes	$-15.84M
EBIT	$-16.64M
EBITDA	$-15.26M
Weighted-Average Shares Outstanding (Basic)	47.80M
Weighted-Average Shares Outstanding (Diluted)	47.80M
Earnings per Share (EPS) (Basic)	$-0.33
Earnings per Share (EPS) (Diluted)	$-0.33
Balance Sheet Financials
Current Assets	$125.43M
Property, Plant, and Equipment	$7.67M
Long-Term Assets	$261.81M
Total Assets	$387.24M
Current Liabilities	$28.31M
Long-Term Debt	$11.60M
Long-Term Liabilities	$11.77M
Total Liabilities	$40.09M
Common Equity	$347.15M
Tangible Shareholders Equity	$126.70M
Shareholders Equity	$347.15M
Common Shares Outstanding	47.85M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$9.10M
Cash Flow from Investing Activities	$-66.71M
Cash Flow from Financial Activities	$-5.87M
Beginning Cash	$95.39M
End Cash	$31.90M
Increase/Decrease in Cash	$-63.48M
Stock-Based Compensation	$10.01M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.43
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.03
Debt to Equity Ratio	0.07
Gross Margin	64.64%
Operating Margin	-65.47%
EBIT Margin	-65.47%
EBITDA Margin	--
Pre-Tax Profit Margin	-61.81%
Profit Margin	-62.30%
Free Cash Flow	$7.18M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.07
Inventory Turnover	0.32
Receiveable Turnover	2.53
Days Sales in Receivables	35.62
Return on Equity	-4.56%
Return on Tangible Equity	-12.50%
Return on Assets	-4.09%
Return on Investments	-4.41%
Book Value Per Share	$7.26
Free Cash Flow per Share	$0.15
Operating Cash Flow per Share	$0.19

Data from Zacks Investment Research, Inc.